AXIS Capital (AXS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Reported Q3 2024 net income available to common shareholders of $173 million ($2.04 per diluted share) and operating income of $230 million ($2.71 per diluted share), with annualized operating ROACE of 17.3% and book value per diluted share rising to $64.65, up 9% in the quarter and 26.3% year-over-year.
Gross premiums written reached a record $1.9 billion, with insurance segment at $1.5 billion, driven by property, credit & political risk, and A&H lines.
Net investment income reached a record $205 million, up 33% year-over-year, fueled by higher yields and increased fixed maturity assets.
Combined ratio for Q3 2024 was 93.1%; for the nine months ended September 30, 2024, combined ratio was 91.6%.
CEO highlighted resilience amid high catastrophe losses, continued operational efficiency, and confidence heading into year-end.
Financial highlights
Net income available to common shareholders was $173 million ($2.04 per diluted share), with operating income of $230 million ($2.71 per diluted share) and annualized operating ROE of 17.3%.
Gross premiums written grew to $1.9 billion, highest Q3 production ever; insurance segment at $1.5 billion, up 5% year-over-year.
Combined ratio was 93.1% for the quarter; insurance at 90.4%, reinsurance at 91.4%.
Net investment income reached $205 million, up 33% year-over-year.
Total capital returned to shareholders year-to-date was $253 million, including $140 million in share repurchases and $113 million in dividends.
Outlook and guidance
Management expressed confidence in future performance, citing strong underwriting, operational efficiency, and focus on specialty underwriting.
Insurance gross premiums growth outlook maintained at the low end of 7%-12% for full-year 2024.
G&A ratio target remains below 11% for full year 2026.
Ongoing share repurchases with $300 million authorized in May 2024; $260 million remains under current program.
AXIS expects to pursue targeted growth in sectors with strong premium adequacy and market dislocations, focusing on disciplined underwriting.
Latest events from AXIS Capital
- Net income rose 33% to $247M, with 11% premium growth and a combined ratio of 89.8%.AXS
Q1 20268 Jul 2026 - Disciplined growth in specialty lines, data-driven underwriting, and capital flexibility define the outlook.AXS
KBW Insurance Conference 20258 Jul 2026 - Record Q2 net income, operating EPS, and capital returns highlight strong specialty growth.AXS
Q2 20241 Jul 2026 - Record Q2 earnings, robust insurance growth, and capital actions drive strong results.AXS
Q2 20251 Jul 2026 - Specialty growth, performance-based pay, strong governance, and ESG leadership highlighted.AXS
Proxy filing1 May 2026 - Record financial performance, strong governance, and robust pay-for-performance alignment highlighted.AXS
Proxy filing2 Apr 2026 - Director elections, executive pay, and auditor appointment headline the 2026 annual meeting.AXS
Proxy filing2 Apr 2026 - Record premiums, 18.3% book value growth, and improved combined ratio marked the year.AXS
Q4 20253 Feb 2026 - LPT with Enstar shifts $2.35B in reserves, boosting specialty focus and capital flexibility.AXS
UBS Global Specialty Insurance/Reinsurance Virtual Conference 202411 Jan 2026